| (Values in U.S. Thousands) | Mar, 2025 | Mar, 2024 | Mar, 2023 | Mar, 2022 | Mar, 2021 |
| Sales | 1,130 | 970 | 920 | 120 | 10 |
| Sales Growth | +16.49% | +5.43% | +666.67% | +1,100.00% | unch |
| Net Income | -8,400 | -10,960 | -8,720 | -5,010 | -3,520 |
| Net Income Growth | +23.36% | -25.69% | -74.05% | -42.33% | -69.23% |
Petvivo Holdings Inc (PETV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
PetVivo Holdings Inc. is an emerging biomedical device company. It focused on the licensing and commercialization of medical devices and therapeutics for pets. PetVivo Holdings Inc. is based in MINNEAPOLIS, MN.
Fiscal Year End Date: 03/31